Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D8LP
|
|||
| Drug Name |
Phenylsulfonyl derivative 3
|
|||
| Synonyms |
PMID29334795-Compound-48
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Central nervous system disease [ICD-11: 8A04-8D87] | Patented | [1] | |
| Company |
OXYGEN HEALTHCARE RESEARCH PVT. LTD SHIRSATH, Vikas S. PATEL, Shailesh M SHETH, Nehal M. SINGH, Jitendra K. PATIL, Pawan D. PAWAR, Anil D. MOTIVARAS, Jitendra D
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H28N2O3S2
|
|||
| Canonical SMILES |
C1CCN(CC1)CCCOC2=CC3=C(C=C2)SCCN3S(=O)(=O)C4=CC=CC=C4
|
|||
| InChI |
1S/C22H28N2O3S2/c25-29(26,20-8-3-1-4-9-20)24-15-17-28-22-11-10-19(18-21(22)24)27-16-7-14-23-12-5-2-6-13-23/h1,3-4,8-11,18H,2,5-7,12-17H2
|
|||
| InChIKey |
DHYQKBDAADLGAK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Histamine H3 receptor (H3R) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Expert Opin Ther Pat. 2018 Mar;28(3):175-196. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.